AMACHOL® cholesterol management

AmaChol® is not only a support for the reduction of LDL cholesterol but also offers benefits in terms of carbohydrate metabolism and inflammatory response. Backed by both preclinical and clinical studies, AmaChol® has demonstrated impressive results:

• In vitro studies at the University of Genoa revealed a significantly lower glycemic index than maltodextrin and a 63.4% reduction in insulin secretion, making it especially valuable for individuals with impaired glucose metabolism, such as those with prediabetes or type 2 diabetes.
• The same studies showed a 69% inhibition of intestinal cholesterol absorption, indicating strong potential for lipid control.

These findings are reinforced by clinical results. In an observational study by NatIng Italia involving overweight subjects with glucose intolerance, AmaChol® supplementation over three months led to:

• Improved postprandial glycemia
• Reduced glycated hemoglobin (HbA1c)
• Decreased total and LDL cholesterol
• Weight loss and a measurable reduction in BMI

Thanks to its multi-targeted action, AmaChol® is an ideal choice for formulations aimed at supporting cardiovascular health, optimising lipid profiles, and promoting metabolic balance—naturally and safely.

In addition, AmaChol® is naturally gluten-free, making it perfectly suited for gluten-free product lines and inclusive formulations that meet a wide range of dietary needs.